Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Aclaris TherapeuticsBellicum PharmaceuticalsForward Pharma A/SIVERIC bioVIVUS
SymbolNASDAQ:ACRSNASDAQ:BLCMNASDAQ:FWPNASDAQ:ISEENASDAQ:VVUS
Price Information
Current Price$1.03$1.19$0.9897$1.18$4.15
52 Week RangeHoldN/AN/AN/AN/A
Analyst Ratings
Consensus RecommendationHoldN/AN/AN/AN/A
Consensus Price Target$17.3333N/AN/AN/AN/A
% Upside from Price Target1,582.85% upsideN/AN/AN/AN/A
Trade Information
Market Cap$44.68 million$55.51 million$46.34 million$48.63 million$43.85 million
Beta0.811.532.311.181.8
Average Volume722,8941,179,565103,32165,533276,323
Sales & Book Value
Annual Revenue$10.09 million$1.12 million$1.25 billion$209.98 million$65.06 million
Price / Sales4.2249.140.040.230.68
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$5.26 per share$1.58 per share$1.74 per share$3.00 per share($3.77) per share
Price / Book0.200.750.570.39-1.10
Profitability
Net Income$-132,740,000.00$-98,040,000.00$-8,720,000.00$63.09 million$-36,950,000.00
EPS($4.03)($2.44)N/A($1.67)($3.48)
Trailing P/E Ratio0.000.000.000.000.00
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-979.65%-4,081.44%N/AN/A-37.95%
Return on Equity (ROE)-81.40%-169.33%N/A-72.53%N/A
Return on Assets (ROA)-60.11%-88.47%N/A-48.53%-9.33%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.22%1.23%N/AN/AN/A
Current Ratio3.23%2.67%121.31%9.31%0.69%
Quick Ratio3.22%2.67%74.53%9.31%0.56%
Ownership Information
Institutional Ownership Percentage86.10%52.21%20.91%39.67%14.72%
Insider Ownership Percentage14.80%2.64%N/A4.30%12.00%
Miscellaneous
Employees16917353557
Shares Outstanding41.37 million46.25 million47.18 million41.56 million10.64 million
Next Earnings Date11/5/2019 (Estimated)11/5/2019 (Estimated)N/A10/30/2019 (Estimated)11/7/2019 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableOptionable
 Aclaris TherapeuticsBellicum PharmaceuticalsForward Pharma A/SIVERIC bioVIVUS

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel